The House is set for a Wednesday vote on the 21st Century Cures Act, the product of nearly three years of intense bipartisan collaboration, consultation with experts and patient groups, and dialogue with medical regulators on the future of biomedical innovation in the U.S.
If passed, the legislation could help companies, researchers, and regulators develop improved paradigms for evaluating medicines developed based on cutting edge science, allowing for safer and more effective medicines to reach patients faster.
